{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:47:59Z","timestamp":1761101279437},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.leukres.2015.03.022","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T03:00:28Z","timestamp":1428634828000},"page":"625-631","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies"],"prefix":"10.1016","volume":"39","author":[{"given":"Takaaki","family":"Konuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Oiwa-Monna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetaka","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arinobu","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2015.03.022_bib0140","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V73.5.1272.bloodjournal7351272","article-title":"Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture","volume":"73","author":"Miyauchi","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.03.022_bib0145","first-page":"239","article-title":"Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia","volume":"13","author":"Takahashi","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.022_bib0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1607","article-title":"Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML","volume":"28","author":"Saito","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.leukres.2015.03.022_bib0155","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa025406","article-title":"Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia","volume":"349","author":"L\u00f6wenberg","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2015.03.022_bib0160","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJM200405203502124","article-title":"Priming with granulocyte colony-stimulating factor \u2013 relation to high-dose cytarabine in acute myeloid leukemia","volume":"350","author":"B\u00fcchner","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2015.03.022_bib0165","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1182\/blood-2011-11-389841","article-title":"Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine","volume":"119","author":"Pabst","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.03.022_bib0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/(SICI)1096-8652(199804)57:4<303::AID-AJH6>3.0.CO;2-Y","article-title":"Recombinant human granulocyte colony-stimulating factor (G-CSF) combined conditioning regimen for allogeneic bone marrow transplantation (BMT) in standard-risk myeloid leukemia","volume":"57","author":"Takahashi","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2015.03.022_bib0175","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2141.1999.01205.x","article-title":"Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony-stimulating factor preceding allogeneic bone marrow transplantation","volume":"104","author":"Okamoto","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2015.03.022_bib0180","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1182\/blood-2006-04-020172","volume":"109","author":"Takahashi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.03.022_bib0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bmt.1705578","article-title":"Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience","volume":"39","author":"Mori","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.022_bib0190","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbmt.2008.03.006","article-title":"Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine","volume":"14","author":"Mori","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.022_bib0195","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.3324\/haematol.2014.114504","article-title":"Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan","volume":"99","author":"Konuma","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2015.03.022_bib0200","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.022_bib0205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.leukres.2015.03.022_bib0210","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","article-title":"Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes","volume":"105","author":"Hsu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.03.022_bib0215","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.022_bib0220","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1200\/JCO.1988.6.4.576","article-title":"High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia","volume":"6","author":"Riddell","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2015.03.022_bib0225","first-page":"9","article-title":"Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens","volume":"6","author":"Woods","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.022_bib0230","first-page":"43","article-title":"Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey","volume":"11","author":"Weyman","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.022_bib0235","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bmt.1700797","article-title":"Toxicity associated with high-dose cytosine arabinoside and total body irradiation as conditioning for allogeneic bone marrow transplantation","volume":"19","author":"Kumar","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.022_bib0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bmt.1700827","article-title":"Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation","volume":"20","author":"Gordon","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.022_bib0245","first-page":"10","article-title":"Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study","volume":"9","author":"Yamada","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2015.03.022_bib0250","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.1994.12.4.671","volume":"12","author":"Estey","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2015.03.022_bib0255","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.bbmt.2014.08.001","volume":"20","author":"Gao","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.022_bib0260","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","article-title":"Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure","volume":"28","author":"Duval","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2015.03.022_bib0265","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/leu.2011.13","article-title":"Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia","volume":"25","author":"Craddock","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2015.03.022_bib0270","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1038\/leu.2013.208","article-title":"The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)","volume":"27","author":"Todisco","year":"2013","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615000934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615000934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T18:07:51Z","timestamp":1598897271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212615000934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0145212615000934"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2015.03.022","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2015.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}